Recent Articles from GlobeNewswire

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Against the backdrop of a significant increase in demand for short-term crypto investment, PFM CRYPTO, a global cryptocurrency cloud mining platform, today announced the launch of its first 2-day short-term XRP cloud mining contract. The contract is open for a limited time from today until June 30, 2025, and each user is limited to one purchase, providing a new option for XRP investors who want to quickly obtain passive income.

Joint effort by law enforcement, non-profits, and corporations leads to recovery of 70 victims and 46 arrests across 19 states, with a focus on illegal massage businesses.

KODIAK, Alaska, May 31, 2025 (GLOBE NEWSWIRE) -- Afognak Native Corporation’s Board of Directors is pleased to announce the hiring of Daniel “Dan” M. Corbett as Chief Executive Officer, leading Afognak into its next phase of growth and business advancement.

MUNICH, Germany, May 31, 2025 (GLOBE NEWSWIRE) -- There was a palpable sense of excitement in Munich as the city prepared to host the UEFA Champions League final between PSG and Inter Milan. Fans from France and Italy – and much further afield – have been gathering in the Bavarian capital for several days.

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001)

NEW HAVEN, Conn. and NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus fulvestrant in adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer (MBC) whose disease progressed following prior treatment with cyclin-dependent kinase (CDK) 4/6 inhibitors and endocrine therapy. These data, which were highlighted in the American Society of Clinical Oncology (ASCO®) press briefing and selected for Best of ASCO, will be presented today in a late-breaking oral presentation (Abstract LBA1000) and have been simultaneously published in the New England Journal of Medicine.

Stafford, Texas and Tuebingen, Germany, May 31, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today announced the presentation of expanded data from the ongoing Phase 1b clinical trial evaluating IMA203 PRAME cell therapy in heavily pretreated patients with metastatic melanoma. The longer follow-up of patients demonstrates a consistent and favorable tolerability profile as well as durable responses with a confirmed ORR of 56%. In addition, the Company provided details from a Trial in Progress poster on SUPRAME, the ongoing Phase 3 clinical trial evaluating IMA203 in patients with unresectable or metastatic cutaneous melanoma who have received prior treatment with a checkpoint inhibitor.

PARIS, France, 31 May 2025 – Late-breaking (LBA4175) post-hoc analysis data from the Phase III NAPOLI 3 study were presented today at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. These results found a median overall survival (mOS) of 19.5 months among long-term survivors (n=15) with metastatic pancreatic adenocarcinoma (mPDAC) treated with the Onivyde® (irinotecan liposome injection) plus oxaliplatin, fluorouracil and leucovorin (NALIRIFOX) regimen as a first-line treatment (n=120), with younger age at diagnosis, and certain tumor and metastasis locations associated with long-term survivorship.2

Students win $3,000 in Shark Tank-style pitch competition and advance to national finals

26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases

Investment Platform’s Users’ Accounts Have Been Frozen Since February

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of investors of fashion startup CaaStle, Inc. Our investigation concerns whether CaaStle has violated the federal securities laws and/or engaged in other unlawful business practices.

PARSIPPANY, N.J. and TEL AVIV, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced results from a study of treatment patterns among patients with tardive dyskinesia (TD) residing in long-term care (LTC) facilities, highlighting a critical gap in TD diagnosis and treatment.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized consumer rights law firm, is investigating potential claims against Traxxas, L.P. ("Traxxas" or the "Company") on behalf of Traxxas customers. Our investigation concerns whether Traxxas has violated consumer protection laws and/or engaged in other unlawful business practices.

PARSIPPANY, N.J. and TEL AVIV, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of real-world clinical outcomes, treatment patterns and healthcare resource utilization (HCRU) data evaluating UZEDY® (risperidone), an extended-release injectable suspension of risperidone for subcutaneous use every one or two months for the treatment of schizophrenia in adults, versus second-generation daily oral options. In the studies, patients receiving UZEDY had lower rates of and longer time to relapse as well as better treatment adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED) visits, shorter hospital length of stay and lower all-cause HCRU. Additionally, Phase 3 SOLARIS data show no incidence of post-injection delirium/sedation syndrome (PDSS) to date in participants taking TEV-'749, a once-monthly, long-acting injectable (LAI) subcutaneous formulation of olanzapine. The systemic safety profile was consistent with approved olanzapine options. The data were presented at the 2025 Psych Congress Elevate Annual Meeting, taking place from May 28-31, 2025, in Las Vegas, Nevada.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE:OGN) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Organon securities between October 31, 2024, to April 30, 2025, both dates inclusive (the “Class Period”). Investors have until July 22, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Ichor Holdings, Ltd. (“Ichor” or the “Company”) (NASDAQ:ICHR) on behalf of Ichor stockholders. Our investigation concerns whether Ichor has violated the federal securities laws and/or engaged in other unlawful business practices.

Portland-based firm introduces transparent, AI-powered platform to help marketers identify true sales drivers and stop wasting budget

“It was an outstanding quarter. We exceeded our Q1 projections with approximately 34% YOY growth from our first two verticals, a clear sign that our strategy is working. We also secured new customers for VSDHOne, positioning us strongly to hit our year-end goals with the number of orders. Our continued investments in the first half of 2025 reflect our commitment to scaling efficiently and driving sustainable margin improvements.” – Shane Madden, CEO of Hydreight

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025.

DALLAS, Texas, May 30, 2025 (GLOBE NEWSWIRE) -- Associa is proud to announce it has been selected as a 2025 US Best Managed Company. Sponsored by Deloitte Private* and The Wall Street Journal, the program recognizes outstanding U.S. private companies.

SEATTLE, May 30, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, announced that updated interim results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET were presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30-June 3, 2025 in Chicago, Illinois.

(All financial figures are expressed in Canadian dollars)

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Highrock Resources Ltd. ("Highrock" or "the Company") (CSE: HRK) is pleased to announce that, further to its press release of May 21, 2025, the Company has made a cash payment in the amount of $8,000 and issued an aggregate of 200,000 common shares (each, a "Common Share") in the capital of the Company to the Optionor (as defined below) at a price of $0.05 per Common Share pursuant to option agreement (the "Option Agreement") with an arm's length optionor (the "Optionor") dated May 12, 2025 (the "Effective Date"), pursuant to which the Company was granted an option (the "Option") to acquire seven (7) mining claims (116 units) (the "Property") in the Minnitaki Lake area located between the towns of Dryden and Sioux Lookout in Northwest Ontario.

New York, May 30, 2025 (GLOBE NEWSWIRE) -- Oak Woods Acquisition Corporation. (Nasdaq: OAKU) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on May 27, 2025, which indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the delayed filing of the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Quarterly Report”). The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the “SEC”). This notification has no immediate effect on the listing of the Company’s securities on Nasdaq.

Demands Management’s Board Nominees John Medland and Emily Jameson Withdraw Immediately or Face Public Complicity in Ongoing Alleged Systemic Violations of Securities Laws

OAKLAND, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (Nasdaq: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today announced its intention to voluntarily delist from The Nasdaq Global Market at the close of markets on June 2, 2025 and to begin trading on the OTCQB® Venture Market of the OTC Markets on June 3, 2025.

SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to patients, today announced the appointment of Matthew Abernethy, M.B.A., to its Board of Directors effective as of May 29, 2025. Mr. Abernethy brings to the Company over 15 years’ experience in corporate finance and investor relations in the biotech and medical device industry. In addition, the Company announced that Timothy P. Coughlin stepped down from the Board of Directors, effective concurrently with Mr. Abernethy’s appointment.

                

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH), the Gen Z engagement platform at the intersection of gaming, college sports, and digital media, today announced that it continues to diligently work on its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025.

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), is providing this bi-weekly update on the status of a management cease trade order granted on May 1, 2025 (the "MCTO") by its principal regulator, the Ontario Securities Commission (the "OSC"), under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On May 2, 2025, the Company announced that there would be a delay in the filing of its annual financial statements, management’s discussion and analysis and related CEO and CFO certificates for the fiscal year ended December 31, 2024 (collectively, the “Annual Filings”), as required under applicable Canadian securities laws (the "Default Announcement"). As stated in the Default Announcement, the Company expects to complete the Annual Filings by June 30, 2025.

WEST DES MOINES, Iowa, May 30, 2025 (GLOBE NEWSWIRE) -- Athene Holding Ltd. (“Athene”) today announced it will redeem all outstanding shares of its 6.375% Fixed-Rate Reset Perpetual Non-Cumulative Preferred Stock, Series C (the “Series C Preferred Stock”), and the corresponding depositary shares (CUSIP: 04686J 309; ISIN: US04686J3095) (the “Depositary Shares”), each representing a 1/1,000th interest in a share of the Series C Preferred Stock.

LAS VEGAS, May 30, 2025 (GLOBE NEWSWIRE) -- Jena Acquisition Corporation II (“Jena II” or the “Company”) announced today the closing of its initial public offering of 23,000,000 units, at a price of $10.00 per unit, which includes 3,000,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full, resulting in gross proceeds of $230,000,000.  The units began trading on the New York Stock Exchange (“NYSE”) on May 29, 2025 under the ticker symbol “JENA.U”. Each unit consists of one Class A ordinary share and one right entitling the holder thereof to receive one-twentieth of one Class A ordinary share upon the consummation of an initial business combination. The Class A ordinary shares and rights comprising the units are expected to begin separate trading no later than the 52nd day following this date. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on the NYSE under the symbols “JENA” and “JENA.R,” respectively.

BEIJING, China, May 30, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that each of the proposed resolutions submitted for shareholder approval (the “Proposed Resolutions”) as set forth in the notice of annual general meeting dated April 23, 2025 (the “AGM Notice”) has been adopted at its annual general meeting of shareholders held in Beijing, China today.

Company becomes sixth corporate partner alongside AB InBev, The Coca-Cola Company, Colgate-Palmolive, Danone, and Unilever

VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced equity inducement grants to seven new non-officer employees consisting of an aggregate of 53,550 share options. All of the foregoing share options were approved by the Compensation Committee of the Company’s Board of Directors with an effective date of May 29, 2025 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

Acquisition will help more organizations transition to the IGEL OS Platform and the IGEL Adaptive Secure Desktop

SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025. UroGen engages in the development and commercialization of solutions for specialty cancers. The Company’s lead pipeline product is UGN-102 (mitomycin), an intravesical solution intended to treat low-grade intermediate risk non-muscle invasive bladder cancer.

SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) --

SANTA MONICA, Calif., May 30, 2025 (GLOBE NEWSWIRE) --  Super League Enterprise, Inc. (NASDAQ: SLE) (the “Company”), a leader in redefining how brands connect with consumers through the power of playable media, today announced that it has entered into definitive agreements in a registered direct offering with an institutional investor for the purchase and sale of approximately $670,000 of shares of Common Stock and Pre-funded Warrants.

Energy solutions sought to add capacity to Avista’s portfolio

BALA CYNWYD, Pa., May 30, 2025 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of TaskUs, Inc. (“TaskUs” or the “Company”) (Nasdaq - TASK) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to an affiliate of Blackstone, TaskUs Co-Founder and Chief Executive Officer Bryce Maddock and TaskUs Co-Founder and President Jaspar Weir (collectively the “Buyer Group”). Under the terms of the transaction, the Buyer Group will acquire all outstanding shares of TaskUs common stock for $16.50 per share in cash.

ATLANTA, May 30, 2025 (GLOBE NEWSWIRE) -- Gray Media announced today that the Radio Television Digital News Association (RTDNA) awarded a combined 81 regional Edward R. Murrow awards for excellence in journalism to 38 of Gray’s local stations, led by 9 separate awards to WMTV in Madison, Wisconsin and 8 to WVUE in New Orleans, Louisiana.   Among the highest honors:

All amounts are in United States dollars, unless otherwise stated.

SAN FRANCISCO, May 30, 2025 (GLOBE NEWSWIRE) -- Yuki, the leader in automated cost optimization for Snowflake, has released its first flagship gated asset: The Ultimate Guide to Snowflake Optimization (2025 Edition), a hands-on playbook for data teams, FinOps leaders, and platform owners navigating the growing complexity (and cost) of large-scale Snowflake environments.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) --

CHANTILLY, Va., May 30, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) chair, president, and chief executive officer, Carey Smith, will present at Baird’s 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025, at approximately 2:35 p.m. Eastern Time.

MIDDLEBURY, Ind., May 30, 2025 (GLOBE NEWSWIRE) -- Winnebago®, a pioneer in recreational vehicles for over six decades, proudly announces the launch of the all-new Thrive™, a high-quality, lightweight, modern travel trailer developed to redefine comfort and design expectations in its category. Thrive represents a renewed energy for the Winnebago brand, reflecting a commitment to delivering innovative, customer-focused RV experiences that elevate owners’ time outside.

SHANGHAI, China, May 30, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced the closing of its previously announced offering of 2.25% convertible senior notes in an aggregate principal amount of US$550 million due 2032 (the “Notes”), which amount reflects the exercise in full by the initial purchasers of their option to purchase an additional US$50 million in aggregate principal amount of the Notes (collectively, the “Notes Offering”). The Notes were offered in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

SHANGHAI, China, May 30, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced the closing of a previously announced registered public offering of 6,000,000 American Depositary Shares (“ADSs”), each representing eight Class A ordinary shares, par value US$0.00005 per share (the “Delta Placement of Borrowed ADSs”), at a public offering price of US$24.50 per ADS (the “Delta Public Offering Price”), which the Company lent (such loaned ADSs, the “Borrowed ADSs”) to an affiliate of the underwriter in the ADS offering (such affiliate, the “ADS Borrower”) pursuant to an ADS lending agreement with the ADS Borrower (the “ADS Lending Agreement”).

SHANGHAI, China, May 30, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced the closing of its previously announced underwritten registered public offering of 5,980,000 American Depositary Shares (“ADSs”), each representing eight Class A ordinary shares, par value US$0.00005 per share (the “Primary ADSs Offering”), at a public offering price of US$24.50 per ADS (the “Primary ADSs Offering Price”), and reflecting the exercise in full by the underwriters of their option to purchase 780,000 additional ADSs.

Nationally recognized curriculum watchdog brings trusted evaluation to early learning, answering urgent demand for quality materials

New INE Security Analysis Shows Targeted Cybersecurity Training Creates Career Stability in Uncertain Times

Transaction in Own Shares

ALISO VIEJO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Pacifica Hotels, a leading owner and operator of boutique hotels on the Pacific Coast, is thrilled to announce that restaurants at eleven properties have been designated Ocean Friendly Restaurants by the Surfrider Foundation. Surfrider’s program highlights restaurants that are committed to making sustainable choices for the ocean and coasts.

Total Voting Rights

DENVER, May 30, 2025 (GLOBE NEWSWIRE) -- In the last year, we’ve seen the first-ever FDA review of psychedelic-assisted therapy and state legislatures debating—and passing—bills to create legal access across the country. As momentum for psychedelic policy reform continues to grow, Psychedelic Science 2025 (PS2025) will convene the world’s leading voices to reflect on lessons learned, assess today’s political landscape, and chart a course for just, compassionate, and responsible psychedelic policy. Hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), this global conference takes place June 16–20, 2025, at the Colorado Convention Center in Denver. Psychedelic Science is the largest psychedelic conference in the world — and this year, its Policy Track stands out as one of the most dynamic forums to discuss the urgent need to create legal access to psychedelic substances, drive drug law reforms, and the transition away from criminalization.

Beginner-friendly crypto mining platform uses artificial intelligence to deliver daily passive income with zero setup required.

FARGO, N.D., May 30, 2025 (GLOBE NEWSWIRE) -- Noridian Healthcare Solutions, LLC (Noridian), a leader in healthcare administration solutions, is proud to announce the promotion of Fred Mamuya, M.D., Ph.D., to an elevated role of Senior Vice President, Chief Medical Officer on Noridian’s senior executive team.

Company Launches Far-Reaching Bitcoin Treasury Strategy

LOS ANGELES, May 30, 2025 (GLOBE NEWSWIRE) -- Flexi-View Lending is proud to announce the successful closing of a $9.5 million commercial loan to support a strategic property acquisition in Dallas, Texas. The loan was secured on an expedited timeline, closing in just 30 days—demonstrating Flexi-View Lending’s commitment to efficient and responsive financing solutions.

WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™.

The effort is MARTA’s largest BRT project to date.

International bestselling author delivers highly anticipated reboot of iconic franchise

EXL Code Harbor™ solution speeds code migration from SAS to Databricks with up to 80% reduction in manual effort

Collaboration aims to increase emergency preparedness and blood donation awareness nationwide

As the global cryptocurrency market climbs steadily, reaching a robust $3.44 trillion in total capitalization, professional investors are increasingly turning to innovative avenues like cloud mining to capitalize on the bullish momentum. Bitcoin remains strong at $108,926.58, while Ethereum surges past $2,600 with a 3.38% increase, signaling solid investor confidence fueled by institutional participation and ETF inflows.

DNMiner is here to simplify the process by offering a new opportunity: short-term cloud mining contracts that let users earn passive income every day — without any upfront hardware costs or complexity.

Set to perform at Spotify House (6/6) and Nissan Stadium (6/8) during CMA Fest next week

 

PHILADELPHIA, May 30, 2025 (GLOBE NEWSWIRE) --

WICHITA, Kan., May 30, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a national senior housing provider headquartered in Wichita, Kansas, has announced it will assume management of four additional communities, expanding its growing portfolio. The properties are located across three states and will now operate under the following names: Hemsley House at University Park (Colorado Springs, CO); Hemsley House of McCandless (Pittsburgh, PA); Hemsley House of Upper St. Clair (Pittsburgh, PA); and Hemsley House of Lenexa (Lenexa, KS). This management transition will take place immediately.